Show simple item record

N-acetyltransferase polymorphism in patients with Behcet's disease

dc.contributor.authorKortunay, S
dc.contributor.authorKayaalp, SO
dc.contributor.authorNacak, M
dc.contributor.authorTunc, R
dc.contributor.authorDincel, A
dc.contributor.authorAynacioglu, AS
dc.contributor.authorBozkurt, A
dc.date.accessioned2021-03-05T16:14:32Z
dc.date.available2021-03-05T16:14:32Z
dc.date.issued2001
dc.identifier.citationAynacioglu A., Bozkurt A., Nacak M., Kortunay S., Tunc R., Dincel A., Kayaalp S., "N-acetyltransferase polymorphism in patients with Behcet's disease", EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, cilt.57, ss.659-662, 2001
dc.identifier.issn0031-6970
dc.identifier.otherav_bfa7d61a-3e0f-4913-9886-db452e41faaa
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/127239
dc.identifier.urihttps://doi.org/10.1007/s002280100365
dc.description.abstractObjectives: The objective of our study was to investigate the possible role of human arylamine N-acetyltransferase 2 (NAT2) polymorphism in susceptibility to Behcet's disease.
dc.language.isoeng
dc.subjectEczacılık
dc.subjectTemel Bilimler
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleN-acetyltransferase polymorphism in patients with Behcet's disease
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
dc.contributor.department, ,
dc.identifier.volume57
dc.identifier.issue9
dc.identifier.startpage659
dc.identifier.endpage662
dc.contributor.firstauthorID163652


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record